FHA
UTMD icon

First Horizon Advisors’s Utah Medical Products UTMD Stock Holding History

First Horizon Advisors’s Portfolio UTMD Stock Details UTMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$33.4K Buy
587
+361
+160% +$19.6K ﹤0.01% 1213
2025
Q1 		$12.7K Buy
226
+21
+10% +$1.26K ﹤0.01% 1510
2024
Q4 		$12.6K Buy
205
+68
+50% +$4.4K ﹤0.01% 1508
2024
Q3 		$9.17K Buy
137
+15
+12% +$1.02K ﹤0.01% 1633
2024
Q2 		$8.15K Buy
122
+35
+40% +$2.38K ﹤0.01% 1610
2024
Q1 		$6.19K Buy
+87
New +$6.53K ﹤0.01% 1758

Other funds holding UTMD

BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
MA
Minerva Advisors Bala Cynwyd, Pennsylvania $155M AUM 35.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

First Horizon Advisors's UTMD Position: Q2 2025 in Review

First Horizon Advisors increased its Utah Medical Products (UTMD) stake by 160% in Q2 2025, buying an estimated $19.6K and bringing the position to 587 shares worth $33.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1213.

First Horizon Advisors first reported a position in UTMD in Q1 2024 and has held it in 6 quarters since. 112 funds tracked by Wall St. Rank hold UTMD as of Q2 2025.

  • First Horizon Advisors held 587 shares of Utah Medical Products worth $33.4K as of Q2 2025.
  • First Horizon Advisors bought 361 Utah Medical Products shares in Q2 2025, an estimated $19.6K.
  • Utah Medical Products made up ﹤0.01% of First Horizon Advisors's portfolio in Q2 2025, its #1213 holding.
  • First Horizon Advisors first reported a position in Utah Medical Products in Q1 2024 and has held it in 6 quarters since.
  • 112 funds tracked by Wall St. Rank held Utah Medical Products as of Q2 2025.

Based on First Horizon Advisors's 13F filing for Q2 2025, filed 6 Aug 2025.